|
GB9827813D0
|
|
Pharmaceutical conjugates
|
|
GB9825105D0
|
|
Pharamaceutical conjugates
|
|
GB9819272D0
|
|
Microparticles
|
|
GB9818018D0
|
|
Microparticles and their use in therapy
|
|
GB9817470D0
|
|
Pharmaceutical formulation
|
|
GB9814172D0
|
|
Formulation for inhalation
|
|
GB9811116D0
|
|
Method of altering heartbeat
|
|
GB9809220D0
|
|
Use of hollow microcapsules in diagnosis and therapy
|
|
GB9803626D0
|
|
Platelet substitutes and their use
|
|
WO9833486A1
|
|
Microparticles and their use in cancer treatment
|
|
GB9801070D0
|
|
HIV inhibition
|
|
GB9800813D0
|
|
Improved ultrasound contrast imaging method and apparatus
|
|
GB9727102D0
|
|
Microparticles and their therapeutic use
|
|
GB9725044D0
|
|
Microparticles and their therapeutic use
|
|
GB9724146D0
|
|
Platelet substitutes and their use
|
|
GB9724143D0
|
|
Pharmaceutical conjugate
|
|
US5961459A
|
|
Use of hollow microcapsules in diagnosis and therapy
|
|
GB9716289D0
|
|
Tumour treatment
|
|
TW416853B
|
|
Microparticles and their use in wound therapy
|
|
ZA9704326B
|
|
Microparticles and their use in wound therapy.
|
